Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital

We investigated the bacterial flora and antimicrobial sensitivity in sputum from patients admitted to hospital with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in order to recommend the best empirical treatment for these patients. The survey was a retrospective study of all patients admitted to Hvidovre hospital with the diagnosis AECOPD during 2004. A total of 118 patients were included. Microscopy, culture and sensitivity testing investigated their sputums. Clinical and paraclinical features were collected from the patients’ files. Among the 118 patients, 59 (50%) had a positive sputum culture. The group with positive cultures had a higher blood neutrophil count (p=0.03). There were no other clinical differences between the groups with and without positive sputum culture. The majority of patients with positive sputum cultures were infected with bacteria other than S. pneumonia, mostly H. influenzae and Moraxella catarrhalis. Patients with low FEV1<1.0 litre were more likely to be infected with Pseudomonas aeruginosa (p=0.03). The sensitivity patterns of the bacteria showed that the majority were resistant to penicillin. If antibiotics are initiated empirically for AECOPD we recommend either cefuroxime for intravenous treatment or amoxicillin-clavulanate for oral treatment.

[1]  R. Rodríguez-Roisín,et al.  Antibiotics for exacerbations of chronic obstructive pulmonary disease. , 2011, The Cochrane database of systematic reviews.

[2]  R. Brand.  Local Chemotherapy with Primary Closure of Septic Wounds by Means of Drainage and Irrigation Cannulae , 2008, Clinical Orthopaedics and Related Research.

[3]  J. Vestbo,et al.  [Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study]. , 2007, Ugeskrift for laeger.

[4]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[5]  E. Fernández-Mondéjar,et al.  Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease , 2006, Critical care medicine.

[6]  G. Davey Smith,et al.  The natural history of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[7]  A. Torres,et al.  Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. , 2005, Archives of internal medicine.

[8]  D. Hui,et al.  Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. , 2005, Respiratory medicine.

[9]  D. Lieberman,et al.  Pseudomonal Infections in Patients with COPD , 2003, American journal of respiratory medicine : drugs, devices, and other interventions.

[10]  J. Garcia-Aymerich,et al.  Bacterial infection in exacerbated COPD with changes in sputum characteristics , 2003, Epidemiology and Infection.

[11]  E. Wouters,et al.  Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. , 2003, Respiratory medicine.

[12]  J. Wedzicha,et al.  Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[13]  A. Bufe,et al.  Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study , 2003, Thorax.

[14]  Andrew J. White,et al.  Chronic obstructive pulmonary disease • 6: The aetiology of exacerbations of chronic obstructive pulmonary disease , 2003, Thorax.

[15]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[16]  T. Seemungal,et al.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations , 2002, Thorax.

[17]  B. Grant,et al.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.

[18]  J. Burns,et al.  Utility of Gram Staining for Evaluation of the Quality of Cystic Fibrosis Sputum Samples , 2002, Journal of Clinical Microbiology.

[19]  M. Miravitlles.  Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? , 2002, European Respiratory Journal.

[20]  N. Høiby.  New antimicrobials in the management of cystic fibrosis. , 2002, The Journal of antimicrobial chemotherapy.

[21]  T. Seemungal,et al.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[22]  R. Stockley,et al.  Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.

[23]  M. Miravitlles,et al.  Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. , 1999, Chest.

[24]  M. Niederman,et al.  Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. , 1998, Chest.

[25]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[26]  R. Rodríguez-Roisín,et al.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.

[27]  C. Larson,et al.  Local chemotherapy with primary closure of septic wounds by means of drainage and irrigation cannulae : M. N. Smith-Petersen MD (1886-1953), Carroll B. Larson MD, Williams Cochran MD . The 12th president of the AAOS 1943 (MNS-P). , 1945, Clinical orthopaedics and related research.

[28]  T. Seemungal,et al.  The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. , 2008, American journal of respiratory and critical care medicine.

[29]  B. Burrows,et al.  Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. , 1969, The New England journal of medicine.